Hemoglobin, lactate dehydrogenase, and facit-fatigue normalization rates in patients treated with pegcetacoplan: Results from the pegasus and prince phase 3 clinical trials

被引：0
|
作者：
Mulherin, B. [1 ]
Yeh, M. [2 ,3 ]
Al-Adhami, M. [3 ]
Savage, J. [3 ]
Dingli, D. [4 ]
机构：
[1] Hematol Oncol Indiana, Indianapolis, IN USA
[2] Ascension St Vincent Carmel, Carmel Valley, CA USA
[3] Apellis Pharmaceut, Waltham, MA USA
[4] Mayo Clin, Rochester, MN USA
来源：
BONE MARROW TRANSPLANTATION | 2022年 / 57卷 / SUPPL 1期
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
P272
引用
下载
收藏
页码：246 / 247
页数：2
相关论文
共 50 条
  • [41] Atezolizumab Versus Docetaxel in Pretreated Patients With NSCLC: Final Results From the Randomized Phase 2 POPLAR and Phase 3 OAK Clinical Trials
    Mazieres, Julien
    Rittmeyer, Achim
    Gadgeel, Shirish
    Hida, Toyoaki
    Gandara, David R.
    Cortinovis, Diego L.
    Barlesi, Fabrice
    Yu, Wei
    Matheny, Christina
    Ballinger, Marcus
    Park, Keunchil
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (01) : 140 - 150
  • [42] Guselkumab Improves Anemia in Patients with Active Psoriatic Arthritis: Results From Two Phase 3 Randomized Controlled Clinical Trials
    Kavanaugh, Arthur
    Liu, Yang
    Rahman, Proton
    Mease, Philip
    Gossec, Laure
    Xu, Lillian
    Hsia, Elizabeth
    Shawi, May
    Han, Chenglong
    Neuhold, Marlies
    Deodhar, Atul
    JOURNAL OF RHEUMATOLOGY, 2022, 49 (07) : 788 - 789
  • [43] Effect of Belimumab Treatment on Renal Outcomes: Results From Phase 3 Belimumab Clinical Trials in Patients with Systemic Lupus Erythematosus
    Dooley, M. A.
    Houssiau, F.
    Aranow, C.
    D'Cruz, D. P.
    Askanase, Anca D.
    Roth, D.
    Zhong, Z. J.
    Freimuth, W.
    Ginzler, E. M.
    ARTHRITIS AND RHEUMATISM, 2011, 63 (10): : S963 - S964
  • [44] Bone mineral density response rates are greater in patients treated with abaloparatide compared with those treated with placebo or teriparatide: Results from the ACTIVE phase 3 trial
    Miller, P. D.
    Hattersley, G.
    Lau, E.
    Fitzpatrick, L. A.
    Harris, A. G.
    Williams, G. C.
    Hu, M. -Y.
    Riis, B. J.
    Russo, L.
    Christiansen, C.
    BONE, 2019, 120 : 137 - 140
  • [45] Relationships Between Fatigue and Hemoglobin/C-Reactive Protein Levels and Associations Between Fatigue and Clinical Response in Patients With Active Psoriatic Arthritis: Results From Two Randomized Controlled Trials of Guselkumab.
    Rahman, Proton
    Mease, Philip
    Deodhar, Atul
    Gossec, Laure
    Kavanaugh, Arthur
    Chakravarty, Soumya
    Kollmeier, Alexa
    Liu, Yang
    Lin, Xiwu
    Shawi, May
    Han, Chenglong
    JOURNAL OF RHEUMATOLOGY, 2022, 49 (07) : 788 - 788
  • [46] Relationships Between Fatigue and Hemoglobin/C-Reactive Protein Levels and Associations Between Fatigue and Clinical Response in Patients with Active Psoriatic Arthritis: Results from Two Randomized Controlled Trials of Guselkumab (TREMFYA®)
    Rahman, Proton
    Mease, Philip
    Deodhar, Atul
    Gossec, Laure
    Kavanaugh, Arthur
    Chakravarty, Soumya
    Kollmeier, Alexa
    Liu, Yan
    Lin, Xiwu
    Shawi, May
    Han, Chenglong
    ARTHRITIS & RHEUMATOLOGY, 2021, 73 : 3768 - 3770
  • [47] Fatigue in patients with moderate to severe plaque psoriasis treated with certolizumab pegol: Three-year results from the CIMPACT phase 3 trial
    Gottlieb, Alice B.
    Soung, Jennifer
    Pinter, Andreas
    Tsai, Tsen-Fang
    Carrascosa, Jose Manuel
    Maul, Julia-Tatjana
    Khattri, Saakshi
    Tilt, Nicola
    Lopez Pinto, Jose M.
    Hellot, Scarlett
    Merola, Joseph F.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2022, 87 (03) : AB168 - AB168
  • [48] Effect of baseline disease characteristics on clinical outcomes in moderate-to-severe Ulcerative Colitis treated with upadacitinib: Results from a Phase 3 trials programme
    Higgins, P.
    Colombel, J. F.
    Reguiero, M.
    Parkes, G.
    Ilo, D.
    Philips, C.
    Yao, X.
    Cheng, E.
    Schreiber, S.
    JOURNAL OF CROHNS & COLITIS, 2022, 16 : I088 - I089
  • [49] EFFECT OF BASELINE DISEASE CHARACTERISTICS ON CLINICAL OUTCOMES IN MODERATE-TO-SEVERE ULCERATIVE COLITIS TREATED WITH UPADACITINIB: RESULTS FROM A PHASE 3 TRIALS PROGRAMME
    Higgins, Peter D.
    Colombel, Jean Frederic
    Regueiro, Miguel D.
    Parkes, Gareth
    Ilo, Dapo
    Philips, Charles
    Yao, Xuan
    Cheng, Erica
    Schreiber, Stefan
    GASTROENTEROLOGY, 2022, 162 (07) : S964 - S964
  • [50] Guselkumab (TREMFYA®) Improves Anemia in Patients with Active Psoriatic Arthritis: Results from Two Phase 3 Randomized Controlled Clinical Trials
    Kavanaugh, Arthur
    Liu, Yan
    Rahman, Proton
    Mease, Philip
    Gossec, Laure
    Xu, Xie
    Hsia, Elizabeth
    Shawi, May
    Han, Chenglong
    Neuhold, Marlies
    Deodhar, Atul
    ARTHRITIS & RHEUMATOLOGY, 2021, 73 : 2763 - 2766
12345